Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...

Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, Memorial ...

Tuesday, January 20, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research ...

Intel Corporation (NASDAQ:INTC) Q4 2025 Earnings Call Transcript January 22, 2026 Intel Corporation beats earnings ...

A new study by researchers in Japan offers new insights into how protocells may have inherited and enriched genetic material before modern biology emerged. By exposing mixed phospholipid vesicles to ...

Modern cells are complex chemical entities with cytoskeletons, finely regulated internal and external molecules, and genetic material that determines ...

Many developers share their LeetCode solutions on GitHub. Look for repositories that are well-organized by topic or problem number, have clear explanations, and show good code quality. Some popular ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Theorem raises $6 million to use AI-powered formal verification to mathematically prove AI-generated code is safe before it's deployed in critical systems.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...